EMILY THOMAS: Open Payments
NPI 1437990975 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,459 in 103 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $296 · 2025 $2,459
Food & beverage: $2,375Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $626 |
| Janssen Biotech, Inc. | 9 | $369 |
| Madrigal Pharmaceuticals | 6 | $234 |
| Regeneron Healthcare Solutions, Inc. | 7 | $175 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $164 |
| Ardelyx, Inc. | 4 | $154 |
| Phathom Pharmaceuticals, Inc. | 13 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $136 |
| GENZYME CORPORATION | 4 | $109 |
| Intercept Pharmaceuticals, Inc. | 5 | $89 |
Products named: TREMFYA, DUPIXENT, REZDIFFRA, XIFAXAN, CREON, IBSRELA, VOQUEZNA, SKYRIZI.
Industry payments across GA — which companies pay providers there.
